<DOC>
	<DOCNO>NCT00305539</DOCNO>
	<brief_summary>Hypothesis : In giant cell arteritis ( GCA ) , short initial treatment anti-TNF may allow fast decrease steroid dosage therefore avoid adverse event steroid .</brief_summary>
	<brief_title>HECTHOR : Humira Spare Steroids Giant Cell Arteritis</brief_title>
	<detailed_description>The protocol consist SC injection adalimumab placebo every 2 week 10 week add steroid</detailed_description>
	<mesh_term>Arteritis</mesh_term>
	<mesh_term>Giant Cell Arteritis</mesh_term>
	<mesh_term>Polymyalgia Rheumatica</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Age â‰¥ 50 year ACR criterion Giant cell arteritis ( HUNDER 1990 ) Positive Temporal artery biopsy Plus standard inclusion criterion Humira protocols Prednisone treatment different disease dose &gt; 15 mg/day Corticoid treatment GCA 10 day GCA treatment prednisone &gt; 1 mg/kg whatever period time GCA treatment antiTNF , MTX , cyclosporine , cyclophosphamide , dapsone steroid bolus Recent , permanent transient visual loss due GCA presence specific visual abnormality ( diplopia , hallucination ) Plus standard exclusion criterion Humira protocol</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Giant Cell Arteritis</keyword>
	<keyword>Placebo</keyword>
	<keyword>Anti-TNF</keyword>
	<keyword>Multicenter-randomized-trial</keyword>
	<keyword>Proved GCA accord ACR criterion ( HUNDER et al 1990 )</keyword>
</DOC>